iRhythm Holdings (IRTC) Profit After Tax (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | iRhythm Holdings | 3.55 Bn | 3.00 Bn | 141.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -349.74% |
| Dec 31, 2025 | 207.04% |
| Sep 30, 2025 | 63.34% |
| Jun 30, 2025 | 53.69% |
| Mar 31, 2025 | -2,203.08% |
| Dec 31, 2024 | 97.11% |
| Sep 30, 2024 | -129.68% |
| Jun 30, 2024 | 55.97% |
| Mar 31, 2024 | -18.01% |
| Dec 31, 2023 | -42.72% |
| Sep 30, 2023 | -46.72% |
| Jun 30, 2023 | 52.74% |
| Mar 31, 2023 | -93.63% |
| Dec 31, 2022 | 5.84% |
| Sep 30, 2022 | 10.24% |
| Jun 30, 2022 | 52.78% |
| Mar 31, 2022 | -55.76% |
| Dec 31, 2021 | -36.91% |
| Sep 30, 2021 | -36.70% |
| Jun 30, 2021 | 37.51% |
| Mar 31, 2021 | -187.84% |
| Dec 31, 2020 | -106.35% |
| Sep 30, 2020 | 77.12% |
| Jun 30, 2020 | -125.45% |
| Mar 31, 2020 | 47.60% |
| Dec 31, 2019 | 5.43% |
| Sep 30, 2019 | -70.56% |
| Jun 30, 2019 | -30.00% |
| Mar 31, 2019 | 49.29% |
| Dec 31, 2018 | -67.27% |
| Sep 30, 2018 | 26.89% |
| Jun 30, 2018 | -20.10% |
| Mar 31, 2018 | 0.65% |
| Dec 31, 2017 | -70.89% |
| Sep 30, 2017 | -1.24% |
| Jun 30, 2017 | -21.52% |
| Mar 31, 2017 | 15.37% |
| Dec 31, 2016 | -53.77% |
| Sep 30, 2016 | 8.14% |
| Jun 30, 2016 | 27.59% |
| Mar 31, 2016 | 20.46% |
| Dec 31, 2015 | -34.04% |